Symbols

OVID

Ovid Therapeutics·NASDAQ

--(--)

OVID Profile

Ovid Therapeutics Inc.

A biopharmaceutical company that develops medicines designed to conquer epilepsies

Industry

Pharmaceutical

Established Date

04/01/2014

Listing Date

05/05/2017

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.ovidrx.com

Security Type

Common stock

Office address

441 Ninth Avenue, 14th Floor, New York, New York 10001

Business

Introduction

Ovid Therapeutics Inc., was incorporated on April 1, 2014 under the laws of the State of Delaware. The company is a biopharmaceutical company focused on developing small molecule drugs for brain diseases by targeting neuronal overexcitement. Its methods are designed to target fundamental biological targets in the central nervous system with a view to halting disease progression and alleviating symptoms.